FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

735068004: Lenvatinib mesilate (substance)

Status: current, Primitive. Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3512974013 Lenvatinib mesylate en Synonym Active Case insensitive SNOMED CT core
3512975014 Lenvatinib mesilate en Synonym Active Case insensitive SNOMED CT core
3726269012 Lenvatinib mesilate (substance) en Fully specified name Active Case insensitive SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lenvatinib mesilate Is modification of Lenvatinib true Inferred relationship Some
Lenvatinib mesilate Is a Enzyme inhibitor false Inferred relationship Some
Lenvatinib mesilate Is a Quinoline true Inferred relationship Some
Lenvatinib mesilate Is a Protein-tyrosine kinase inhibitor true Inferred relationship Some
Lenvatinib mesilate Is a Substance with cyclopropane structure true Inferred relationship Some
Lenvatinib mesilate Has disposition Vascular endothelial growth factor receptor antagonist true Inferred relationship Some
Lenvatinib mesilate Is a Vascular endothelial growth factor receptor antagonist true Inferred relationship Some
Lenvatinib mesilate Is a Antineoplastic agent true Inferred relationship Some
Lenvatinib mesilate Is a Phenylurea compound true Inferred relationship Some
Lenvatinib mesilate Is a Lenvatinib false Inferred relationship Some
Lenvatinib mesilate Has disposition Protein-tyrosine kinase inhibitor true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Lenvatinib (as lenvatinib mesilate) 10 mg oral capsule Has precise active ingredient True Lenvatinib mesilate Inferred relationship Some 1
Lenvatinib (as lenvatinib mesilate) 4 mg oral capsule Has precise active ingredient True Lenvatinib mesilate Inferred relationship Some 1

Reference Sets

Substance foundation reference set

Back to Start